Molecular Toxicology in Human Kidney Cells
人肾细胞的分子毒理学
基本信息
- 批准号:7216674
- 负责人:
- 金额:$ 21.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1999
- 资助国家:美国
- 起止时间:1999-09-15 至 2009-03-31
- 项目状态:已结题
- 来源:
- 关键词:AchievementAcuteAddressAffectAnimalsApoptosisApoptoticCarcinogensCell CycleCell Cycle RegulationCell DeathCell Membrane PermeabilityCell ProliferationCell physiologyCellsChemicalsComplexConditionCultured CellsCysteineDNA DamageDataDependenceDoseEnvironmentEnvironmental PollutionEpigenetic ProcessEvaluationEventExperimental ModelsExposure toFundingGeneticGlutathioneGoalsGrowthHealthHumanInduction of ApoptosisInjuryInternational Agency for Research on CancerKidneyKidney NeoplasmsMalignant neoplasm of kidneyMediatingMetabolismMitochondriaMitotic Cell CycleMolecular ToxicologyNational Toxicology ProgramNatural regenerationNecrosisNephrotoxicOrganPathway interactionsPersonal SatisfactionProcessProteinsRangeRenal carcinomaResearchResearch PersonnelRisk AssessmentRodentSignal PathwaySignal Transduction PathwaySignaling MoleculeSolventsSulfoxideTestingTimeTissuesToxic effectTrichloroethyleneTubular formationTumor Necrosis Factor Ligand Superfamily Member 6United States Environmental Protection AgencyWorkWorkplacebiological adaptation to stresscell growth regulationcell injuryflavin-containing monooxygenasegenetic regulatory proteininnovationinsightkidney cellmitochondrial dysfunctionmitochondrial membranenephrotoxicitypreventprogramsprotein expressionrepairedresearch studyresponsespecies differencetumorigenesis
项目摘要
DESCRIPTION (provided by applicant): Trichloroethylene (TRI) is a major environmental contaminant, is an established animal carcinogen, and is considered a "probably human carcinogen" by the National Toxicology Program and the International Agency for Research on Cancer. The kidneys are one target organ for TRI and its nephrotoxic and nephrocarcinogenic effects are mediated by metabolites derived from conjugation with glutathione (GSH). Subsequent metabolism to the cysteine conjugate S- (1,2- dichlorovinyl)-L-cysteine (DCVC) generates the penultimate toxic metabolite. It is metabolism of DCVC by either the cysteine conjugate ¿-Iyase or the flavin-containing monooxygenase that generates the ultimate reactive and toxic species. Most of the previous research that has delineated the metabolism and potential modes of action for TRI and DCVC has been performed in rodents or with tissue from rodents. While these studies, some of which have been done by the PI, have provided much useful insight, there are problems in using data obtained from rodents for human health risk assessment. This is particularly true for halogenated solvents such as TRI, because of marked species differences in metabolism, transport, and overall sensitivity to toxicity. Previous studies of ours showed that DCVC can cause both apoptosis or necrosis in primary cultures of human proximal tubular (hPT) cells, depending on concentration and time of exposure. Findings also suggested effects of DCVC on expression of proteins related to stress response and regulation of cell growth. This application uses primary cultures of hPT cells as the experimental model and will investigate the ability of hPT cells exposed to moderately toxic concentrations of DCVC to undergo repair and regeneration, the potential for DCVC to induce cell proliferation by non-genotoxic mechanisms, and the requirement for mitochondrial toxicity in the course of events leading from exposure to toxicity. The application comprises three Specific Aims. Specific Aim 1 addresses the question of whether hPT cells exposed to moderately toxic concentrations of DCVC undergo repair and regeneration. Several markers of repair will be assessed and precise conditions and potential mechanisms by which the repair and regeneration response are induced will be investigated. Specific Aim 2 will address the question of whether DCVC can stimulate uncontrolled proliferation of hPT cells. Effects on cell cycle and cell cycle signaling molecules under various conditions of DCVC exposure will be studied. Finally, Specific Aim 3 will address the question of whether mitochondrial toxicity is sufficient and necessary for DCVC-induced toxicity in hPT cells. Although previous work has shown that mitochondria are early and potently affected intracellular targets of DCVC, it is not known whether mitochondrial toxicity is an obligatory step in the progression of events that occur after DCVC exposure or whether other pathways that are independent of mitochondria can mediate renal cell injury. Achievement of these aims should build on our previous work in human kidney cells and extend it to provide a much more complete understanding of the various and complex ways in which DCVC affects the human kidney
描述(由申请人提供): 三氯乙烯(TRI)是一种主要的环境污染物,是一种已确定的动物致癌物,并且被国家毒理学计划和国际癌症研究机构认为是“可能的人类致癌物”。肾脏就是其中之一。 TRI 的靶器官及其肾毒性和肾癌作用是由与谷胱甘肽 (GSH) 结合的代谢产物介导的。半胱氨酸缀合物 S-(1,2-二氯乙烯基)-L-半胱氨酸 (DCVC) 产生倒数第二个有毒代谢物,它是半胱氨酸缀合物 ¿ -Iyase 或含黄素的单加氧酶,可产生最终的反应性和毒性物质。 先前描述 TRI 和 DCVC 的代谢和潜在作用模式的研究大多是在啮齿类动物或啮齿类动物的组织中进行的。其中一些是由 PI 完成的,提供了许多有用的见解,但使用从啮齿动物获得的数据进行人类健康风险评估存在问题,对于 TRI 等卤化溶剂尤其如此,因为。我们之前的研究表明,根据浓度和暴露时间,DCVC 可导致人近端肾小管 (hPT) 细胞的原代培养物凋亡或坏死。 DCVC 对与应激反应和细胞生长调节相关的蛋白质表达的影响本申请使用 hPT 细胞的原代培养物作为实验模型,并将研究暴露于中等毒性浓度的 DCVC 的 hPT 细胞进行修复和再生的能力。 , 这DCVC 通过非基因毒性机制诱导细胞增殖的潜力,以及在暴露于毒性的主要事件过程中对线粒体毒性的要求。具体目标 1 解决了 hPT 细胞是否适度暴露的问题。修复和再生过程中 DCVC 的毒性浓度将被评估,并且将研究诱导修复和再生反应的精确条件和潜在机制。具体目标 2 将解决 DCVC 是否可以刺激不受控制的增殖的问题。最后,特定目标 3 将研究 DCVC 暴露的各种条件下对细胞周期和细胞周期信号分子的影响,即线粒体毒性对于 DCVC 诱导的 hPT 细胞毒性是否充分且必要。研究表明,线粒体是 DCVC 的早期且有效影响的细胞内靶标,目前尚不清楚线粒体毒性是否是 DCVC 暴露后发生的事件进展中的必然步骤,或者独立于线粒体的其他途径是否可以介导肾细胞损伤。这些目标的实现应该建立在我们之前在人类肾细胞方面的工作的基础上,并将其扩展以提供对 DCVC 影响人类肾脏的各种复杂方式的更全面的了解
项目成果
期刊论文数量(4)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Acute, subacute, and subchronic oral toxicity studies of 1,1-dichloroethane in rats: application to risk evaluation.
- DOI:10.1093/toxsci/64.1.135
- 发表时间:2001-11
- 期刊:
- 影响因子:0
- 作者:S. Muralidhara;R. Ramanathan;S. M. Mehta;L. H. Lash;Daniel Acosta;James V. Bruckner
- 通讯作者:S. Muralidhara;R. Ramanathan;S. M. Mehta;L. H. Lash;Daniel Acosta;James V. Bruckner
Hepatic and renal toxicities associated with perchloroethylene.
- DOI:
- 发表时间:2001-06
- 期刊:
- 影响因子:21.1
- 作者:L. Lash;J. C. Parker
- 通讯作者:L. Lash;J. C. Parker
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LAWRENCE H. LASH其他文献
LAWRENCE H. LASH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LAWRENCE H. LASH', 18)}}的其他基金
Mitochondrial and Cellular Biomarkers of Renal Injury from Environmental and Therapeutic Agents
环境和治疗药物引起的肾损伤的线粒体和细胞生物标志物
- 批准号:
10388109 - 财政年份:2021
- 资助金额:
$ 21.47万 - 项目类别:
Mitochondrial and Cellular Biomarkers of Renal Injury from Environmental and Therapeutic Agents
环境和治疗药物引起的肾损伤的线粒体和细胞生物标志物
- 批准号:
10559604 - 财政年份:2021
- 资助金额:
$ 21.47万 - 项目类别:
相似国自然基金
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
Tenascin-X对急性肾损伤血管内皮细胞的保护作用及机制研究
- 批准号:82300764
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
ACSS2介导的乙酰辅酶a合成在巨噬细胞组蛋白乙酰化及急性肺损伤发病中的作用机制研究
- 批准号:82370084
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
KIF5B调控隧道纳米管介导的线粒体转运对FLT3-ITD阳性急性髓系白血病的作用机制
- 批准号:82370175
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
PHF6突变通过相分离调控YTHDC2-m6A-SREBP2信号轴促进急性T淋巴细胞白血病发生发展的机制研究
- 批准号:82370165
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
相似海外基金
Optimizing HEALing in Ohio Communities (OHiO)-Health Equity Supplement
优化俄亥俄州社区 (OHiO) 的治疗 - 健康公平补充
- 批准号:
10890393 - 财政年份:2023
- 资助金额:
$ 21.47万 - 项目类别:
Enhancing Hypnotic Medication Discontinuation in Primary Care through Supervised Medication Tapering and Digital Cognitive Behavioral Insomnia Therapy
通过监督药物逐渐减量和数字认知行为失眠治疗,加强初级保健中催眠药物的停药
- 批准号:
10736443 - 财政年份:2023
- 资助金额:
$ 21.47万 - 项目类别:
Molecular analysis of glutamatergic neurons derived from iPSCs containing PPM1D truncating mutations found in Jansen de Vries Syndrome
Jansen de Vries 综合征中发现的含有 PPM1D 截短突变的 iPSC 衍生的谷氨酸能神经元的分子分析
- 批准号:
10573782 - 财政年份:2023
- 资助金额:
$ 21.47万 - 项目类别:
Integrated Treatment for Enhancing Growth in Recovery during Adolescence (InTEGRA)
促进青春期恢复生长的综合治疗 (InTEGRA)
- 批准号:
10680616 - 财政年份:2023
- 资助金额:
$ 21.47万 - 项目类别: